Should we really worry about “launch delays” of new drugs in OECD countries? Livio GarattiniSimone Ghislandi Editorial 21 December 2006 Pages: 1 - 3
Cost of breast cancer in Sweden in 2002 Mathias LidgrenNils WilkingBengt Jönsson Original paper 11 January 2007 Pages: 5 - 15
Better primary physician services lead to fewer hospital admissions Fredrik CarlsenJostein GryttenIrene Skau Original paper 13 December 2006 Pages: 17 - 24
Utility loss and indirect costs following cardiovascular events in hypertensive patients: the ASCOT health economic substudy Peter LindgrenThomas Kahanon behalf of the ASCOT investigators Original paper 13 December 2006 Pages: 25 - 30
Risk-adjusted capitation payments: how well do principal inpatient diagnosis-based models work in the German situation? Results from a large data set Corinne BehrendFlorian BuchnerJürgen Wasem Original paper 27 January 2007 Pages: 31 - 39
Long-term absenteeism due to sickness in Sweden. How long does it take and what happens after? Daniela Andrén Original paper 16 January 2007 Pages: 41 - 50
Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany B. BrüggenjürgenP. LindgrenS. N. Willich Original paper 21 December 2006 Pages: 51 - 57
A multilevel analysis on the determinants of regional health care expenditure: a note Guillem López-CasasnovasMarc Saez Original paper 21 December 2006 Pages: 59 - 65
Resource use and costs associated with patients treated for depression in primary care P. SobockiM. EkmanB. Jönsson Original paper 13 December 2006 Pages: 67 - 76
A public–private analysis of the new Dutch health insurance system Hans MaarseYvette Bartholomée Original paper 16 December 2006 Pages: 77 - 82